As of Jul 22
| -0.01 / -0.33%|
The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 17.00, with a high estimate of 17.00 and a low estimate of 17.00. The median estimate represents a +462.91% increase from the last price of 3.02.
The current consensus among 1 polled investment analysts is to Buy stock in Adamis Pharmaceuticals Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.